System Analysis Based on Lipid-Metabolism-Related Genes Identifies AGT as a Novel Therapy Target for Gastric Cancer with Neoadjuvant Chemotherapy
Gastric cancer (GC) is one of the most common causes of cancer-related deaths worldwide, and chemotherapy is still a standard strategy for treating patients with advanced GC. Lipid metabolism has been reported to play an important role in the carcinogenesis and development of GC. However, the potent...
Saved in:
Main Authors: | Le Zhu (Author), Ming Ma (Author), Lumin Zhang (Author), Shun Wang (Author), Yu Guo (Author), Xinxin Ling (Author), Hanchao Lin (Author), Nannan Lai (Author), Shengli Lin (Author), Ling Du (Author), Qiongzhu Dong (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis
by: Shaoji Zhao, et al.
Published: (2024) -
Prognostic Model of D2 Radical Gastrectomy Combined with Neoadjuvant Chemotherapy for Gastric Cancer
by: Wang G, et al.
Published: (2023) -
Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
by: Shirin Kianersi, et al.
Published: (2023) -
Neoadjuvant Chemotherapy Current Applications in Clinical Practice
Published: (2012) -
Neoadjuvant Chemotherapy Increasing Relevance in Cancer Management
Published: (2013)